Clinical trial
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory…
NCT00231491 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00231491 |
|---|---|
| Title | Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder. |
| Official title | Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder (OAB). A Multicenter Phase II, Randomized, Double-blind, Placebo Controlled 6 Month Study . VESITOX |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug |
| Interventions | Botulinum Toxin A (Botox ) |
| Enrollment | 160 |
| Start date | Nov 1, 2005 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Oct 4, 2005 |
| Last update posted | Feb 17, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: